Is there a role for reactive oxygen species in arterial medial elastocalcinosis?

Vascular Pharmacology

Volumn 46, Issue 3, 2007, Pages 201-206

  Lalaoui, Moulay Zyad ^a   El Midaoui, Adil ^a   de Champlain, Jacques ^a   Moreau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alpha lipoic acid; Isolated systolic hypertension; Oxidative stress; Vascular calcification

Indexed keywords

ANTIOXIDANT; PHYTOMENADIONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THIOCTIC ACID; VITAMIN K GROUP; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CALCIFICATION; ARTERY MEDIA; ARTERY MEDIA ELASTOCALCINOSIS; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR SYSTEM; CAROTID ARTERY; CONTROLLED STUDY; DIET; DRUG INHIBITION; DRUG MECHANISM; FEMORAL ARTERY; HEART LEFT VENTRICLE HYPERTROPHY; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PULSE WAVE; RAT; RIGIDITY; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC HYPERTENSION;

ANIMALS; ARTERIES; CALCINOSIS; DIETARY FATS; HYPERTROPHY, LEFT VENTRICULAR; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDES; THIOCTIC ACID; VASCULAR DISEASES; VITAMIN K; WARFARIN;

EID: 33846221497     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.10.006     Document Type: Article

References (29)

1. Blacher J., Demuth K., Guerin A.P., Safar M.E., Moatti N., and London G.M. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 535-541
2. Blacher J., Asmar R., Djane S., London G.M., and Safar M.E. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33 (1999) 1111-1117
3. Blumenthal H.T., Lansing A.I., and Wheeler P.A. Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, ageing and disease. Am. J. Pathol. 20 (1944) 665-679
4. Csiszar A., Pacher P., Kaley G., and Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr. Vasc. Pharmacol. 3 (2005) 285-291
5. Dao H.H., Essalihi R., Graillon J.F., Lariviere R., de Champlain J., and Moreau P. Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. J. Hypertens. 20 (2002) 1597-1606
6. Dao H.H., Essalihi R., Bouvet C., and Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc. Res. 66 (2005) 307-317
7. Davies M.R., and Hruska K.A. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 60 (2001) 472-479
8. de Champlain J., Wu R., Girouard H., Karas M., E.L.M. A., Laplante M.A., and Wu L. Oxidative stress in hypertension. Clin. Exp. Hypertens. 26 (2004) 593-601
9. Essalihi R., Dao H.H., Yamaguchi N., and Moreau P. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K(1) treatment. Am. J. Hypertens. 16 (2003) 103-110
10. Essalihi R., Dao H.H., Gilbert L.A., Bouvet C., Semerjian Y., McKee M.D., and Moreau P. Regression of medial elastocalcinosis in the rat aorta: a new vascular function for carbonic anhydrase. Circulation 112 (2005) 1628-1635
11. Farsang C., and Sleight P. Isolated systolic hypertension: cardiovascular risk and treatment benefits. J. Hypertens. 19 (2001) 2279-2281
12. Giachelli C.M., Speer M.Y., Li X., Rajachar R.M., and Yang H. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ. Res. 96 (2005) 717-722
13. Izzo, J.L., Shykoff, B.E., Jr., 2001. Arterial stiffness: clinical relevance, measurement, and treatment. Rev. Cardiovasc. Med. 2 29-34, 37-40.
14. Laplante M.A., Wu R., El Midaoui A., and de Champlain J. NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells. J. Hypertens. 21 (2003) 927-936
15. Laplante M.A., Wu R., Moreau P., and de Champlain J. Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. Free Radic. Biol. Med. 38 (2005) 589-596
16. Lartaud-Idjouadiene I., Lompré A.-M., Kieffer P., Colas T., and Atkinson J. Cardiac consequences of prolonged exposure to an isolated increase in aortic stiffness. Hypertension 34 (1999) 63-69
17. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., Ducimetiere P., and Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
18. Laurent S., Kingwell B., Bank A., Weber M., and Struijker-Boudier H. Clinical applications of arterial stiffness: therapeutics and pharmacology. Am. J. Hypertens. 15 (2002) 453-458
19. Lehto S., Niskanen L., Suhonen M., Ronnemaa T., and Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 978-983
20. Li L., Fink G.D., Watts S.W., Northcott C.A., Galligan J.J., Pagano P.J., and Chen A.F. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107 (2003) 1053-1058
21. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., and Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (1997) 78-81
22. Midaoui A.E., Elimadi A., Wu L., Haddad P.S., and de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am. J. Hypertens. 16 (2003) 173-179
23. Moe S.M., and Chen N.X. Inflammation and vascular calcification. Blood Purif. 23 (2005) 64-71
24. Price P.A., Faus S.A., and Williamson M.K. Warfarin causes rapid calcification of elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1400-1407
25. Qunibi W.Y., Nolan C.A., and Ayus J.C. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon. Kidney Int., Suppl. (2002) 73-80
26. Sachidanandam K., Fagan S.C., and Ergul A. Oxidative stress and cardiovascular disease: antioxidants and unresolved issues. Cardiovasc. Drug Rev. 23 (2005) 115-132
27. Schurgers L.J., Teunissen K.J., Knapen M.H., Kwaijtaal M., van Diest R., Appels A., Reutelingsperger C.P., Cleutjens J.P., and Vermeer C. Novel conformation-specific antibodies against matrix {gamma}-carboxyglutamic acid (Gla) protein. Undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1629-1633
28. Wu R., Laplante M.A., and De Champlain J. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J. Hypertens. 22 (2004) 793-801
29. Yang X., Sreejayan N., and Ren J. Views from within and beyond: narratives of cardiac contractile dysfunction under senescence. Endocrine 26 (2005) 127-137